Acid Reducer Tablet, Delayed Release
NDC Package 70000-0521-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Acid Reducer (omeprazole) tablets is ranitidine is known as an H2 blocker. This formulation utilizes a tablet, delayed release delivery system. Marketed by Cardinal Health, this product is identified by NDC 70000-0521 and is authorized under FDA application ANDA206877.

Identification & Billing

NDC Package Code
70000-0521-2
Package Description
1 BLISTER PACK in 1 CARTON / 14 TABLET, DELAYED RELEASE in 1 BLISTER PACK
Product Code
70000-0521
11-Digit Billing Format
70000052102
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 402014 - omeprazole 20 MG Delayed Release Oral Tablet
  • RxCUI: 402014 - omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet

Clinical Specifications

Proprietary Name
Acid Reducer
Non-Proprietary Name
Omeprazole
Substance Name
Omeprazole Magnesium
Dosage Form
Tablet, Delayed Release - A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
OMEPRAZOLE MAGNESIUM 20 mg/1
Pharmacologic Class
Usage Information
Ranitidine is known as an H2 blocker. It works by reducing the amount of acid in your stomach. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). This drug has been withdrawn from the US market due to problems with safety. A possible cancer-causing impurity has been found in some ranitidine products.

Regulatory & Marketing

Labeler Name
Cardinal Health
Product Type
Human Otc Drug
FDA Application #
ANDA206877
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-06-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70000-0521). Click a package code to view its specific billing and regulatory data.

70000-0521-1
1 BOTTLE in 1 CARTON / 14 TABLET, DELAYED RELEASE in 1 BOTTLE
70000-0521-3
2 BOTTLE in 1 CARTON / 14 TABLET, DELAYED RELEASE in 1 BOTTLE
70000-0521-4
3 BOTTLE in 1 CARTON / 14 TABLET, DELAYED RELEASE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70000-0521-2 identifies a specific commercial package of 1 blister pack in 1 carton / 14 tablet, delayed release in 1 blister pack of Acid Reducer, a human over the counter drug labeled by Cardinal Health. This tablet, delayed release is formulated for oral use and contains omeprazole magnesium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cardinal Health on June 06, 2018. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Ranitidine is known as an H2 blocker. It works by reducing the amount of acid in your stomach. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). This drug has been withdrawn from the US market due to problems with safety. A possible cancer-causing impurity has been found in some ranitidine products.

How is this Cardinal Health product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70000052102. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70000-0521-2
11-Digit CMS (5-4-2)
70000-0521-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.